Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation

Keyphrases

• Cholesterol 100%
• Non-alcoholic Fatty Liver Disease (NAFLD) 100%
• Systemic Inflammation 100%
• Liver 83%
• Aorta 66%
• Toll-like 50%
• Cholesteryl Ester 33%
• Cellular Response 16%
• Carrageenan 16%
• Inflammation 16%
• Receptor 2 16%
• Hypercholesterolemia 16%
• Between-group 16%
• Subcutaneous Injection 16%
• Systemic Inflammation Response Index 16%
• Fibrosis 16%
• New Zealand White Rabbit 16%
• High Cholesterol 16%
• I to 16%
• Cell Surface Receptor 16%
• Triglyceride Accumulation 16%
• Intimal Hyperplasia 16%
• Wild Animals 16%
• Foam Cells 16%
• Cholesterol Metabolites 16%
• Fatty Change 16%
• Cholesterol Diet 16%
• Advanced Lesions 16%
• Serum Expression 16%
• Inflammatory Receptors 16%
• Early Lesions 16%

Medicine and Dentistry

• Nonalcoholic Fatty Liver 100%
• Atherosclerosis 100%
• Receptor 33%
• Toll Like Receptor 4 33%
• Cholesterol Diet 33%
• Cholesterol Ester 33%
• Toll Like Receptor 2 16%
• Metabolite 16%
• Hypercholesterolemia 16%
• Fibrosis 16%
• Triacylglycerol 16%
• Subcutaneous Injection 16%
• Carrageenan 16%
• Intimal Hyperplasia 16%
• Foam Cell 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Wild Animal 16%